Topic Progress:

COMMONEST ASMs

This page doesn’t discuss all ASMs and isn’t an exhaustive pharmacology resource.

Focus is on the common medications and practically important aspects.

Epilepsy.com is more expansive resource with more ASMs

TIER 1 ASMS

BENZODIAZEPINES

> Mechanism: bind to GABA-A receptor and increase membrane permeability to Cl-

> This magnifies the inhibitory action of GABA on neuronal excitability

> Cannot be used in the long term due to the development of tolerance

> Sudden discontinuation of long term benzodiazepines can cause withdrawal seizures

> Side effects: drowsiness/sedation, tolerance, hypotension, respiratory depression / airway compromise, confusion, delirium, amnesia

> Need to be given over at least 2 minutes, as rapid injection can cause respiratory depression or hypotension

DOSE

5-10 mg IV/IM OR 5-10 mg buccally/ intranasally over 2 minutes

PROS

Can be given when IV access is not available

CONS

Confusion, delirium

In higher doses causes airway compromise

Duration of action means neuro exam confounded for a while after administering

Amnestic properties

 

DOSE

4 mg or 0.1 mg/kg IV over 2 minutes, repeat after 5 minutes if required

PROS

Longer acting than others in class, so decreases risk of seizure recurrence

CONS

Not readily available in Australia in injectable form

DOSE

10 mg IV OR 10-20 mg rectally, repeat after 10-15 minutes if required.

Over 2 minutes. Rapid injection can cause respiratory depression or hypotension

PROS

Can be given when IV access is not available

CONS

Delayed respiratory depression can occur with rectal administration

DOSE

1 mg IV

Dilute in 1 mL of water, then give over 2 minutes

TIER 2 ASMS

Mechanism

Unknown. May modulate GABA and glutamate release. May bind to synaptic vesicle protein 2A

Dose

For ongoing SE, 60 mg/kg IV (max 4.5 g) over 15 minutes

Pros

Minimal drug interactions

Less side effects than other Tier 2 therapies

Cons

May cause:

> Dizziness

> Headache

> Irritability, mood changes including suicidal ideation

> Loss of strength and energy, lethargy

> Loss of coordination

Rare but more serious:

> Anaphylaxis

> Stevens-Johnson syndrome, toxic epidermal necrolysis

Mechanism

Sodium channel blockade. Thus prevents repetitive neuronal discharge.

Dose

20mg/kg IV, no faster than 50 mg /min (e.g. over 45 minutes)

Pros

Minimal drug interactions

Less side effects than other Tier 2 therapies

Cons

IV formulation in 40% propylene glycol; this causes hypotension & arrhythmia, hence need for slow administration

Many interactions SEE

May cause:

> Nystagmus

> Decreased coordination

> Shaking of the hands

> Slowed thinking and movement

> Memory problems

> Slurred speech

> Poor concentration

> 10% get rash

> Deranged LFT’s

Rare but more serious:

> Anaphylaxis

Mechanism

Increases sodium channel inactivation.

Increases GABA by inhibiting GABA transaminase. May increase GABA synthesis by activating GAD

Dose

40 mg/kg IV (max 3 g) over 5-10 minutes

Pros

Non-sedating

Most have no side effects

Cons

Should be avoided in hepatic impairment.

May cause:

> Lethargy, mental slowing

> Dizziness

> GI upset including vomiting

> Tremor

> Hair loss

> Weight gain

> Changes in behavior (depression in adults, irritability in children)

Rare but more serious:

> Liver failure

> Thrombocytopenia and bleeding

> Hyperammonaemic encephalopathy

> Pancreatitis

> Anaphylaxis

TIER 3 ASMS

Mechanism

GABA-A agonist

Dose

1-2 mg/kg IV over 5 min. Repeat 0.5-2 mg/kg boluses q3-5 min until seizures stop. Max loading 10 mg/kg

Often limited by hypotension

Infusion: 1 mg/kg/h  (80 kg = 8 ml/h), then titrate up to max 4 mg/kg/h (80 kg = 32 ml/h)

>4 mg/kg/h risks PRIS (80 kg = 32 ml/h)

Pros

> Rapid acting

> Terminates seizures

> Reduces cerebral metabolic rate

> Reduces ICP

> Wears off fast so neurological assessment possible

> Very few drug interactions

Cons

> Hypotension

> Respiratory depression, usually necessitates intubation and ventilation at these doses

> May get rebound seizures with abrupt cessation

> At high doses (>4 mg/kg/h) risk of Propofol infusion syndrome PRIS

More info here

Mechanism

Enhances the slow inactivation of Na channels thus stabilising hyperexcitable neuronal membranes and preventing repetitive neuronal firing

Dose

Loading dose: 400-600 mg IV over 15 minutes REF

Then 200 mg BD

IV and enteral formulations available

Pros

> Effective

> Non-sedating, ideal if trying to avoid general anaesthesia

> Safety: few patients have side effects

Cons

Possible side effects:

> Deranged LFTs so monitor

> Neutropenia, anaemia

> Increased PR on ECGs so do daily ECGs

> Increased risk of atrial fibrillation

> Coordination problems, unsteady gait

> Dizziness, double vision

> Headache

> Nausea, vomiting

> Lethargy

TIER 4 ASMS

Mechanism

NMDA receptor antagonist

Dose

Load: 1-2 mg/kg, max 4.5 mg/kg

Infusion: 1-10 mg/kg/h

Pros

Much more haemodynamically stable than propofol, midazolam or thiopentone

Doesn’t cause respiratory depression

Relatively safe

Cons

Efficacy in terminating refractory SE is really unknown REVIEW

May cause:

> Tachyarrhythmias

> Hypertension

> Hypersalivation

> Hallucinations

> Ulcerative cystitis, secondary renal damage and hepatic failure can occur with high doses of oral ketamine, not reported from use in critical care

REF

Mechanism

GABA-A agonist. Highly lipid soluble.

Dose

Load: 2-7 mg/kg over 50 mg/min, with additional boluses 1-2 mg/kg as required

Infusion: 0.5-5 mg/kg/h titrate to seizure control on EEG

Pros

> Effective anti-seizure medication

> Rapid onset

> Reduces cerebral metabolic rate

> Reduces ICP

Cons

Many.

You are committing to a long course of management with several potential life threatening complications.

Causes profound anaesthesia and when high doses given with a prolonged infusion takes days to weeks to wear off.

> Hypotension usually requires noradrenaline to offset

> Hypokalaemia due to intracellular shift with associated arrhythmia

> Rebound hyperkalaemia when thio stopped with associated arrhythmia

> Immunosuppression, pneumonia common

> Ileus guaranteed, often refractory until thio stopped

Case Study Icon GandB

Sharon has been treated with midazolam and levetiracetam.

It’s suggested to you that you should have used fosphenytoin as it’s better at controlling seizures.

What do you reply?

Not true!

> Evidence suggests levetiracetam, valproate, phenytoin and fosphenytoin are about equivalent in controlling as tier 2 treatments of SE after a benzodiazepine

> The ESETT trial found fosphenytoin, valproate and levetiracetam to be equally effective as IV loading in SE with no difference in safety.

> A systematic review and meta-analysis of 9 studies and 1732 patients found no difference in treatment success (i.e. seizure cessation) in the use of levetiracetam compared to phenytoin.

An observational study of 5265 patients found no difference in efficacy or safety between phenytoin and fosphenytoin.

You can’t get fosphenytoin in Australia at present.

The pros of fosphenytoin are that you can give it IV quickly, no need for an intravenous filter, and there’s a lower potential for local tissue and cardiac toxicity.

Levetiracetam is usually used because:

> Better side effect profile than phenytoin

> Slightly better side effect profile than valproate

> Much cheaper than IV valproate

Log in with your credentials

Forgot your details?